Innocan Pharma Stock Market Value
| INNPF Stock | USD 5.76 0.16 2.70% |
| Symbol | InnoCan |
InnoCan Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to InnoCan Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of InnoCan Pharma.
| 12/14/2025 |
| 01/13/2026 |
If you would invest 0.00 in InnoCan Pharma on December 14, 2025 and sell it all today you would earn a total of 0.00 from holding InnoCan Pharma or generate 0.0% return on investment in InnoCan Pharma over 30 days. InnoCan Pharma is related to or competes with Goodness Growth, SymBio Pharmaceuticals, and RetinalGenix Technologies. InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms comb... More
InnoCan Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure InnoCan Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess InnoCan Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 30.69 | |||
| Value At Risk | (13.46) |
InnoCan Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for InnoCan Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as InnoCan Pharma's standard deviation. In reality, there are many statistical measures that can use InnoCan Pharma historical prices to predict the future InnoCan Pharma's volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.77) | |||
| Treynor Ratio | 1.23 |
InnoCan Pharma Backtested Returns
InnoCan Pharma holds Efficiency (Sharpe) Ratio of -0.22, which attests that the entity had a -0.22 % return per unit of risk over the last 3 months. InnoCan Pharma exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out InnoCan Pharma's Market Risk Adjusted Performance of 1.24, standard deviation of 5.03, and Risk Adjusted Performance of (0.16) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.95, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning InnoCan Pharma are expected to decrease slowly. On the other hand, during market turmoil, InnoCan Pharma is expected to outperform it slightly. At this point, InnoCan Pharma has a negative expected return of -1.1%. Please make sure to check out InnoCan Pharma's value at risk, as well as the relationship between the rate of daily change and period momentum indicator , to decide if InnoCan Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
InnoCan Pharma has no correlation between past and present. Overlapping area represents the amount of predictability between InnoCan Pharma time series from 14th of December 2025 to 29th of December 2025 and 29th of December 2025 to 13th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of InnoCan Pharma price movement. The serial correlation of 0.0 indicates that just 0.0% of current InnoCan Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.49 |
InnoCan Pharma lagged returns against current returns
Autocorrelation, which is InnoCan Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting InnoCan Pharma's otc stock expected returns. We can calculate the autocorrelation of InnoCan Pharma returns to help us make a trade decision. For example, suppose you find that InnoCan Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
InnoCan Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If InnoCan Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if InnoCan Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in InnoCan Pharma otc stock over time.
Current vs Lagged Prices |
| Timeline |
InnoCan Pharma Lagged Returns
When evaluating InnoCan Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of InnoCan Pharma otc stock have on its future price. InnoCan Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, InnoCan Pharma autocorrelation shows the relationship between InnoCan Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in InnoCan Pharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in InnoCan OTC Stock
InnoCan Pharma financial ratios help investors to determine whether InnoCan OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoCan with respect to the benefits of owning InnoCan Pharma security.